Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2026 16:05 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2026 financial and operating results on...
June 25, 2026 16:05 ET | Source: Nasdaq, Inc.

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 15, 2026

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 15, 2026, short interest in 3,764 Nasdaq Global Market℠ securities totaled 17,903,270,409 shares compared with...
June 25, 2026 16:01 ET | Source: Ligand Pharmaceuticals

Ligand Announces Closing of Convertible Senior Notes Offering

Ligand Announces Closing of Convertible Senior Notes Offering
June 25, 2026 16:01 ET | Source: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by...
June 25, 2026 16:01 ET | Source: Keros Therapeutics, Inc.

Keros Therapeutics Appoints Anne Prener to its Board of Directors

LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...
June 25, 2026 16:01 ET | Source: Ascendis Pharma

Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026

COPENHAGEN, Denmark, June 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children...
June 25, 2026 16:01 ET | Source: Wise Group plc

Wise Group plc reports Full Year 2026 Financial Results

Wise Group plc reports Full Year 2026 Financial Results
June 25, 2026 16:01 ET | Source: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102 regardless of age or disease severity ...
June 25, 2026 16:00 ET | Source: Farmers & Merchants Bancorp, Inc.

F&M Bank Announces Executive Leadership Appointments to Support Continued Growth and Strategic Execution

ARCHBOLD, Ohio, June 25, 2026 (GLOBE NEWSWIRE) -- F&M Bank today announced several executive leadership appointments designed to strengthen operational execution, enhance legal and compliance...
June 25, 2026 16:00 ET | Source: MKS Inc.

MKS Expanding Manufacturing Capability to Enable Next Wave of AI Build-Out

ANDOVER, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced the expansion of its Atotech equipment...